Literature DB >> 1885209

Inhibition of production and function of interleukin-6 by 1,25-dihydroxyvitamin D3.

K Müller1, M Diamant, K Bendtzen.   

Abstract

1,25-Dihydroxyvitamin D3 (1,25-(OH)2D3) has been shown to interfere with immunoglobulin production and lymphocyte proliferation in vitro. These lymphocyte functions are influenced by interleukin (IL)-6 produced by antigen presenting cells. Hence, the ability of 1,25-(OH)2D3 to interfere with the production and function of IL-6 was investigated. 1,25-(OH)2D3 and the analogue MC 903 inhibited IL-6 production by LPS-stimulated human mononuclear cells. The precursor 25-OH D3 was ineffective. Likewise, 1,25-(OH)2D3 but not 25-OH D3 inhibited rIL-6-driven as well as rIL-1 alpha/beta-driven proliferation of murine thymocytes. This effect of 1,25-(OH)2D3 was partially or totally overcome by larger concentrations of rIL-6 as well as by rIL-2 and ionomycin. Consistently, the production of IL-6 and IL-2 in rIL-1 driven thymocyte cultures were found to be reduced by 1,25-(OH)2D3. Inhibition of production and function of IL-6 may therefore be involved in 1,25-(OH)2D3-mediated regulation of lymphocyte functions in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885209     DOI: 10.1016/0165-2478(91)90108-m

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  32 in total

1.  [Letter query to Zeitschrift für Rheumatologie by Dr. med. Ilka Schwarze FA of Internal Medicine and Rheumatology Center of Internal Medicine--Leipzig University Clinic].

Authors:  Stephan Scharla
Journal:  Z Rheumatol       Date:  2005-03       Impact factor: 1.372

2.  Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.

Authors:  Corrilynn O Hileman; Vin Tangpricha; Abdus Sattar; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

3.  Single and combined effects of the vitamin D analogue KH1060 and cyclosporin A on mercuric-chloride-induced autoimmune disease in the BN rat.

Authors:  S T Lillevang; J Rosenkvist; C B Andersen; S Larsen; E Kemp; T Kristensen
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

4.  Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis.

Authors:  L Yazmalar; L Ediz; M Alpayci; O Hiz; M Toprak; I Tekeoglu
Journal:  Afr Health Sci       Date:  2013-03       Impact factor: 0.927

5.  Effects of a short-term calcium and vitamin D treatment on serum cytokines, bone markers, insulin and lipid concentrations in healthy post-menopausal women.

Authors:  M H Gannagé-Yared; M Azoury; I Mansour; R Baddoura; G Halaby; R Naaman
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

6.  Dietary vitamin D affects cell-mediated hypersensitivity but not resistance to experimental pulmonary tuberculosis in guinea pigs.

Authors:  E Hernandez-Frontera; D N McMurray
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Partial prevention of active Heymann nephritis by 1 alpha, 25 dihydroxyvitamin D3.

Authors:  D D Branisteanu; P Leenaerts; B van Damme; R Bouillon
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

Review 8.  Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcidol.

Authors:  Johann D Ringe; Erich Schacht
Journal:  Rheumatol Int       Date:  2004-06-30       Impact factor: 2.631

9.  Vitamin D therapy in experimental allergic encephalomyelitis could be limited by opposing effects of sphingosine 1-phosphate and gelsolin dysregulation.

Authors:  Yanyan Zhu; Zhaoyu Qin; Jifang Gao; Mingchong Yang; Yanjiang Qin; Ting Shen; Shilian Liu
Journal:  Mol Neurobiol       Date:  2014-04-11       Impact factor: 5.590

10.  The in vivo effect of a new, in vitro, extremely potent vitamin D3 analog KH1060 on the suppression of renal allograft rejection in the rat.

Authors:  E Lewin; K Olgaard
Journal:  Calcif Tissue Int       Date:  1994-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.